291 related articles for article (PubMed ID: 31428086)
1. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
Front Immunol; 2019; 10():1712. PubMed ID: 31428086
[TBL] [Abstract][Full Text] [Related]
2. Determinants of C1q binding in the single antigen bead assay.
Schaub S; Hönger G; Koller MT; Liwski R; Amico P
Transplantation; 2014 Aug; 98(4):387-93. PubMed ID: 24918611
[TBL] [Abstract][Full Text] [Related]
3. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
[TBL] [Abstract][Full Text] [Related]
4. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
5. Effects of weak/non-complement-binding HLA antibodies on C1q-binding.
Hönger G; Amico P; Arnold ML; Spriewald BM; Schaub S
HLA; 2017 Aug; 90(2):88-94. PubMed ID: 28585289
[TBL] [Abstract][Full Text] [Related]
6. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
7. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
[TBL] [Abstract][Full Text] [Related]
8. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Anti-HLA Antibodies of Highly Sensitized Patients by Single Antigen Bead and C1q Tests.
Ayna TK; Koçyİğİt AÖ; Soypaçaci Z; Tuğmen C; Pirim I
Transplant Proc; 2019 May; 51(4):1024-1026. PubMed ID: 31101164
[TBL] [Abstract][Full Text] [Related]
10. Investigating the relationship between class I HLA-specific immunoglobulin-G subclasses, Pan-IgG single antigen bead assays and complement mediated interference in sera from renal transplant recipients.
Goldsmith P; Lowe D; Wong C; Ridgway D; Howse M; Hammad A; Mehra S; Christmas S; Jones A
Transpl Immunol; 2020 Dec; 63():101332. PubMed ID: 32927096
[TBL] [Abstract][Full Text] [Related]
11. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.
Lefaucheur C; Viglietti D; Bentlejewski C; Duong van Huyen JP; Vernerey D; Aubert O; Verine J; Jouven X; Legendre C; Glotz D; Loupy A; Zeevi A
J Am Soc Nephrol; 2016 Jan; 27(1):293-304. PubMed ID: 26293822
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation.
Lee KH; Won DI; Yook JM; Kim KY; Park SM; Park JH; Lee ES; Lim JH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Kim HK; Huh S; Cho JH
Transplant Proc; 2018 May; 50(4):1063-1067. PubMed ID: 29731066
[TBL] [Abstract][Full Text] [Related]
13. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
Chen G; Sequeira F; Tyan DB
Hum Immunol; 2011 Oct; 72(10):849-58. PubMed ID: 21791230
[TBL] [Abstract][Full Text] [Related]
14. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
15. Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome.
Molina J; Navas A; Agüera ML; Rodelo-Haad C; Alonso C; Rodríguez-Benot A; Aljama P; Solana R
Front Immunol; 2017; 8():1310. PubMed ID: 29163462
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity.
Zhao J; Fu YX; Yang T; Shen ZY; Wu CL
Transplant Proc; 2016; 48(6):2235-40. PubMed ID: 27569975
[TBL] [Abstract][Full Text] [Related]
17. In-Depth Analysis of Anti-HLA Antibodies Using C1q Assay.
Zielińska H; Zieliński M; Dębska-Zielkowska J; Dukat-Mazurek A; Moszkowska G; Lewandowska D; Dębska-Ślizień A; Trzonkowski P
Transplant Proc; 2022 May; 54(4):934-939. PubMed ID: 35534279
[TBL] [Abstract][Full Text] [Related]
18. The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation.
Valenzuela NM; Schaub S
Transplantation; 2018 Jan; 102(1S Suppl 1):S7-S13. PubMed ID: 29266057
[TBL] [Abstract][Full Text] [Related]
19. Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?
Cicciarelli JC; Lemp NA; Chang Y; Koss M; Hacke K; Kasahara N; Burns KM; Min DI; Naraghi R; Shah T
J Immunol Res; 2017; 2017():1652931. PubMed ID: 28182088
[TBL] [Abstract][Full Text] [Related]
20. Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring.
Ponsirenas RVG; Cazarote HB; Araújo SA; Wanderley DC; Shimakura S; Valdameri JS; Contieri FLC; von Glehn CCQC; Susin MF; Sotomaior VS
Transplant Direct; 2018 Sep; 4(9):e385. PubMed ID: 30234154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
